More on zts
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $77.10 |
|
|||
| Open | $77.91 | ||||
| 52 Wk High | $53.14 | ||||
| 52 Wk Low | $38.26 | ||||
| Day High | $77.93 | ||||
| Day Low | $76.15 | ||||
| P/E | 76.11 | ||||
| EPS | $1.01 | ||||
| Volume | 866,060 | ||||
- Zoetis Inc. (ZTS) PT Lowered to $94 at TD Cowen
- Form 3 Zoetis Inc. For: Aug 17 Filed by: SACCARO JAMES
- Zoetis Inc. (ZTS) PT Lowered to $80 at Stifel as Key Franchise Price Realization Decelerates
- Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
- FDA grants emergency use for Simparica TRIO to treat screwworm in dogs
- FDA: issues Emergency Use Authorization for Simparica Trio to treat new world screwworm in dogs & puppies
- Form 4 Zoetis Inc. For: Aug 07 Filed by: DAMELIO FRANK A
- Zoetis Inc. (ZTS) PT Lowered to $80 at UBS
- Zoetis Inc. (ZTS) PT Lowered to $115 at JPMorgan
- Form 8-K Zoetis Inc. For: Aug 06
Entities mentioned with zts
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Pershing Square Capital | View Related Stories »
- Show More...
